APP-Mediated Mechanical Signaling and its Regulation by Alzheimer's Risk Genes
About the Research Project
Program
Award Type
Standard
Award Amount
$114,126
Active Dates
January 01, 2026 - December 31, 2027
Grant ID
CA2026002
Goals
Demonstrate that APP is under mechanical tension in neurons and test whether Alzheimer’s disease risk genes disrupt this force-sensitive signaling pathway.
Summary
Our preliminary data revealed for the first time that APP is connected to the force-generation machinery via its interaction with a protein called talin. When combined with the known capacity of APP molecules to interact with each other, this immediately indicated a new role for APP as a tension-bearing linkage and mechanical sensor, where APP cleavage in healthy brains may act as a signal to maintain synaptic health. This provides a big hypothesis for a mechanical basis of Alzheimer’s disease, where disruption of neuronal mechanics contributes to the mis-processing of APP.
Unique and Innovative
If we can prove that APP is a force-bearing molecule and under tension, this will transform the field of Alzheimer’s Disease as we will show a role for APP that is novel, and identify a new cause of the disease. The mechanical signaling machinery that would be maintaining this linkage is well studied in diseases like cancer. We predict that this study will validate a new therapeutic approach for treating Alzheimer’s by targeting neuronal mechanics to slow the spread, and there are a wide range of drugs already on the market for treating cellular mechanics in other diseases.
Foreseeable Benefits
If we can prove that APP is a force-bearing molecule and under tension, this will transform the field of Alzheimer’s Disease as we will show a role for APP that is novel, and identify a new cause of the disease. The mechanical signaling machinery that would be maintaining this linkage is well studied in diseases like cancer. We predict that this study will validate a new therapeutic approach for treating Alzheimer’s by targeting neuronal mechanics to slow the spread, and there are a wide range of drugs already on the market for treating cellular mechanics in other diseases.
Related Grants
Alzheimer's Disease Research
Linking Plaque Shapes to Amyloid Structures in Alzheimer’s Disease
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Anllely Fernandez, PhD
Current Organization
Indiana University
Linking Plaque Shapes to Amyloid Structures in Alzheimer’s Disease
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Anllely Fernandez, PhD
Current Organization
Indiana University
Alzheimer's Disease Research
Amyloid Precursor Protein Processing Through a Novel Pathway in Alzheimer's Disease
Active Dates
July 01, 2025 - June 30, 2028
Principal Investigator
Justyna Dobrowolska Zakaria, PhD
Current Organization
Northwestern University
Amyloid Precursor Protein Processing Through a Novel Pathway in Alzheimer's Disease
Active Dates
July 01, 2025 - June 30, 2028
Principal Investigator
Justyna Dobrowolska Zakaria, PhD
Current Organization
Northwestern University
Alzheimer's Disease Research
Exploring the Origin and Composition of a Unique Pathology in Alzheimer's Disease
Active Dates
July 01, 2025 - June 30, 2028
Principal Investigator
Cyril Pottier, PhD
Current Organization
Washington University in St.Louis
Exploring the Origin and Composition of a Unique Pathology in Alzheimer's Disease
Active Dates
July 01, 2025 - June 30, 2028
Principal Investigator
Cyril Pottier, PhD
Current Organization
Washington University in St.Louis